Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Grey

Showing results (231-240 of 256) with videos related to

Pageof 26
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 2007
Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanismsSusannah O'Sullivan, Dorit Naot, Karen Callon, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2013
Low-dose fluoride in postmenopausal women: a randomized controlled trialAndrew Grey, Sanjay Garg, Michael Dray, et al.
Biochemical and Biophysical Research Communications|November 26, 2009
Evidence for a role for the p110-alpha isoform of PI3K in skeletal functionAndrew Grey, Claire Chaussade, Victoria Empson, et al.
Molecular Endocrinology (Baltimore, Md.)|June 5, 2004
The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cellsAndrew Grey, Tatjana Banovic, Qing Zhu, et al.
Biochemical and Biophysical Research Communications|April 28, 2004
Shared pathways of osteoblast mitogenesis induced by amylin, adrenomedullin, and IGF-1Jillian Cornish, Andrew Grey, Karen E Callon, et al.
Archives of Internal Medicine|November 13, 2008
Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older menIan R Reid, Ruth Ames, Barbara Mason, et al.
BMJ (Clinical Research Ed.)|January 17, 2008
Vascular events in healthy older women receiving calcium supplementation: randomised controlled trialMark J Bolland, P Alan Barber, Robert N Doughty, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 24, 2006
Deletion of aspartate 182 in OPG causes juvenile Paget's disease by impairing both protein secretion and binding to RANKLCatherine Middleton-Hardie, Qing Zhu, Harry Cundy, et al.
Calcified Tissue International|October 28, 2010
Imatinib mesylate does not increase bone volume in vivoSusannah O'Sullivan, Dorit Naot, Karen E Callon, et al.
The New Zealand Medical Journal|September 28, 2011
Prevalent dietary supplement use in older New Zealand menCatherine J Bacon, Mark J Bolland, Ruth W Ames, et al.
Pageof 26

Showing results (231-240 of 256) with videos related to

Sort By:
Pageof 26
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 2007
Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanismsSusannah O'Sullivan, Dorit Naot, Karen Callon, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2013
Low-dose fluoride in postmenopausal women: a randomized controlled trialAndrew Grey, Sanjay Garg, Michael Dray, et al.
Biochemical and Biophysical Research Communications|November 26, 2009
Evidence for a role for the p110-alpha isoform of PI3K in skeletal functionAndrew Grey, Claire Chaussade, Victoria Empson, et al.
Molecular Endocrinology (Baltimore, Md.)|June 5, 2004
The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cellsAndrew Grey, Tatjana Banovic, Qing Zhu, et al.
Biochemical and Biophysical Research Communications|April 28, 2004
Shared pathways of osteoblast mitogenesis induced by amylin, adrenomedullin, and IGF-1Jillian Cornish, Andrew Grey, Karen E Callon, et al.
Archives of Internal Medicine|November 13, 2008
Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older menIan R Reid, Ruth Ames, Barbara Mason, et al.
BMJ (Clinical Research Ed.)|January 17, 2008
Vascular events in healthy older women receiving calcium supplementation: randomised controlled trialMark J Bolland, P Alan Barber, Robert N Doughty, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 24, 2006
Deletion of aspartate 182 in OPG causes juvenile Paget's disease by impairing both protein secretion and binding to RANKLCatherine Middleton-Hardie, Qing Zhu, Harry Cundy, et al.
Calcified Tissue International|October 28, 2010
Imatinib mesylate does not increase bone volume in vivoSusannah O'Sullivan, Dorit Naot, Karen E Callon, et al.
The New Zealand Medical Journal|September 28, 2011
Prevalent dietary supplement use in older New Zealand menCatherine J Bacon, Mark J Bolland, Ruth W Ames, et al.
Pageof 26